67 filings
Page 4 of 4
8-K
om7sl5
24 Jun 19
Applied Therapeutics Announces Initiation of Phase 1/2 Study of AT-007 In Galactosemia
7:09am
8-K
3yy9x95lukl
21 Jun 19
Applied Therapeutics Reports First Quarter 2019 Financial Results
7:34am
8-K
m0fhok
7 Jun 19
AT-001, a novel, potent and selective aldose reductase inhibitor, is expected to start a pivotal study later this year
7:59am
8-K
hyokn1os k6nvrk
6 Jun 19
Departure of Directors or Certain Officers
4:05pm
8-K
byptxwsa iqzmjtfuacs
28 May 19
Applied Therapeutics Announces Fda Orphan Drug Designation for AT-007 In Galactosemia
5:14pm
8-K
4e1t27kj
24 May 19
Other Events
4:24pm
8-K
x3yo5dd9rt23 z0c0a3
16 May 19
Amendments to Articles of Incorporation or Bylaws
5:22pm